An abundance of research has documented elevated expression levels of TRPM8 (transient receptor potential melastatin 8) in the spinal cord and DRG of neuropathic pain animal models, positing TRPM8 as a promising therapeutic target (93, 94). The gene discussed is TRPM8; the disease is neuropathic pain.